{"id":"https://openalex.org/W2109728136","doi":"https://doi.org/10.2174/1389450033490902","title":"Non-steroidal Anti-inflammatory Drugs and Cyclooxygenase in Alzheimer s Disease","display_name":"Non-steroidal Anti-inflammatory Drugs and Cyclooxygenase in Alzheimer s Disease","alternate_titles":[],"publication_year":2003,"publication_date":"2003-08-01","ids":{"openalex":"https://openalex.org/W2109728136","doi":"https://doi.org/10.2174/1389450033490902","mag":"2109728136","pmid":"https://pubmed.ncbi.nlm.nih.gov/12866660"},"language":"en","primary_location":{"id":"doi:10.2174/1389450033490902","doi":"https://doi.org/10.2174/1389450033490902","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1389450033490902","pdf_url":null,"source":{"id":"https://openalex.org/S140884253","display_name":"Current Drug Targets","issn_l":"1389-4501","issn":["1389-4501","1873-5592"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Drug Targets","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2109728136"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027733537","display_name":"Jeroen J.M. Hoozemans","orcid":"https://orcid.org/0000-0002-2888-8967","observed_orcids":["https://orcid.org/0000-0002-2888-8967"]},"institutions":[{"id":"https://openalex.org/I865915315","display_name":"Vrije Universiteit Amsterdam","ror":"https://ror.org/008xxew50","country_code":"NL","type":"education","lineage":["https://openalex.org/I865915315"]},{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jeroen Hoozemans","raw_affiliation_strings":["Department of Pathology, Graduate School Neurosciences Amsterdam, Research Institute Neurosciences, VU university medical center, Amsterdam, The Netherlands. jjm.hoozemans@vumc.nl","Department of Pathology, Graduate School Neurosciences Amsterdam, Research Institute Neurosciences, VU university medical center, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Graduate School Neurosciences Amsterdam, Research Institute Neurosciences, VU university medical center, Amsterdam, The Netherlands. jjm.hoozemans@vumc.nl","institution_ids":["https://openalex.org/I865915315","https://openalex.org/I911458345"]},{"raw_affiliation_string":"Department of Pathology, Graduate School Neurosciences Amsterdam, Research Institute Neurosciences, VU university medical center, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053882105","display_name":"Robert Veerhuis","orcid":"https://orcid.org/0000-0003-0869-621X","observed_orcids":["https://orcid.org/0000-0003-0869-621X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robert Veerhuis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014287588","display_name":"Annemieke J.M. Rozem\u00fcller","orcid":"https://orcid.org/0000-0003-2528-4428","observed_orcids":["https://orcid.org/0000-0003-2528-4428"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Annemieke Rozemuller","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5082860350","display_name":"Piet Eikelenboom","orcid":"https://orcid.org/0000-0001-7767-1732","observed_orcids":["https://orcid.org/0000-0001-7767-1732"]},"institutions":[{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Piet Eikelenboom","raw_affiliation_strings":["Department of Pathology, Division of Neuropathology, VU university medical center, P.O. Box 7057,1007 MB Amsterdam, The Netherlands.,Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Division of Neuropathology, VU university medical center, P.O. Box 7057,1007 MB Amsterdam, The Netherlands.,Netherlands","institution_ids":["https://openalex.org/I911458345"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5082860350"],"corresponding_institution_ids":["https://openalex.org/I911458345"],"apc_list":null,"apc_paid":null,"fwci":3.2038,"has_fulltext":false,"cited_by_count":92,"citation_normalized_percentile":{"value":0.93213103,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"4","issue":"6","first_page":"461","last_page":"468"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9150000214576721,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9150000214576721,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.060499999672174454,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":0.016899999231100082,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9549999833106995},{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.9929999709129333},{"id":"https://openalex.org/keywords/cyclooxygenase","display_name":"cyclooxygenase","score":0.9760000109672546},{"id":"https://openalex.org/keywords/cox-2-inhibitors","display_name":"COX-2 inhibitors","score":0.8029999732971191},{"id":"https://openalex.org/keywords/cox-1","display_name":"cyclooxygenase-1","score":0.9860000014305115},{"id":"https://openalex.org/keywords/neuroinflammation","display_name":"neuroinflammation","score":0.8059999942779541},{"id":"https://openalex.org/keywords/anti-inflammatory-therapy","display_name":"anti-inflammatory therapy","score":0.8870000243186951},{"id":"https://openalex.org/keywords/alzheimer-s-disease-pathogenesis","display_name":"Alzheimer's disease pathogenesis","score":0.8709999918937683},{"id":"https://openalex.org/keywords/clinical-trial-failure","display_name":"clinical trial failure","score":0.5759999752044678}],"concepts":[{"id":"https://openalex.org/C2779689624","wikidata":"https://www.wikidata.org/wiki/Q410251","display_name":"Cyclooxygenase","level":3,"score":0.8025301694869995},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7622636556625366},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.6623766422271729},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.6543649435043335},{"id":"https://openalex.org/C2780942790","wikidata":"https://www.wikidata.org/wiki/Q372016","display_name":"Pathogenesis","level":2,"score":0.6434106826782227},{"id":"https://openalex.org/C2779703632","wikidata":"https://www.wikidata.org/wiki/Q581996","display_name":"Anti-inflammatory","level":2,"score":0.5534614324569702},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.5410526990890503},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5374195575714111},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5338797569274902},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.32811659574508667},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22187349200248718},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.14971205592155457},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.08910417556762695},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007527","descriptor_name":"Isoenzymes","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D008565","descriptor_name":"Membrane Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011451","descriptor_name":"Prostaglandin-Endoperoxide Synthases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D051545","descriptor_name":"Cyclooxygenase 1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051546","descriptor_name":"Cyclooxygenase 2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052246","descriptor_name":"Cyclooxygenase 2 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.2174/1389450033490902","doi":"https://doi.org/10.2174/1389450033490902","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1389450033490902","pdf_url":null,"source":{"id":"https://openalex.org/S140884253","display_name":"Current Drug Targets","issn_l":"1389-4501","issn":["1389-4501","1873-5592"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Drug Targets","raw_type":"journal-article"},{"id":"pmid:12866660","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12866660","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current drug targets","raw_type":"Journal Article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/685ad15c-8659-4b04-856d-025cea77be18","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/685ad15c-8659-4b04-856d-025cea77be18","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hoozemans, J J M, Veerhuis, R, Rozemuller, A J M & Eikelenboom, P 2003, 'Non-steroidal anti-inflammatory drugs and cyclooxygenase in Alzheimer's disease', Current drug targets, vol. 4, no. 6, pp. 461-468. https://doi.org/10.2174/1389450033490902","raw_type":"info:eu-repo/semantics/review"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/2f707965-21d0-49e1-a554-538d9cefed56","doi":null,"is_oa":false,"landing_page_url":"https://pure.amc.nl/en/publications/nonsteroidal-antiinflammatory-drugs-and-cyclooxygenase-in-alzheimers-disease(2f707965-21d0-49e1-a554-538d9cefed56).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Current drug targets, 4(6), 461 - 468. Bentham Science Publishers B.V.","raw_type":"info:eu-repo/semantics/other"},{"id":"pmh:vumc:oai:pure.atira.dk:publications/e642d22a-8171-4839-8aa2-c173124bc0d8","doi":null,"is_oa":false,"landing_page_url":"https://research.vumc.nl/en/publications/e642d22a-8171-4839-8aa2-c173124bc0d8","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Current Drug Targets, 4(6), 461 - 468. Bentham Science Publishers B.V.","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2027043109","https://openalex.org/W1591558381","https://openalex.org/W2110542500","https://openalex.org/W1966012148","https://openalex.org/W1968431776","https://openalex.org/W2015246311","https://openalex.org/W2012109987","https://openalex.org/W2061333828","https://openalex.org/W93511798","https://openalex.org/W2382700202"],"abstract_inverted_index":{"Epidemiological":[0],"studies":[1],"indicate":[2],"that":[3,33],"anti-inflammatory":[4,9,54,106,147],"drugs,":[5],"especially":[6],"the":[7,13,29,44,65,70,91,102,105,120,133,143,150],"non-steroidal":[8],"drugs":[10],"(NSAIDs),":[11],"decrease":[12],"risk":[14],"of":[15,41,46,56,93,98,104,125,135,145,154],"developing":[16],"Alzheimer's":[17],"disease":[18],"(AD).":[19],"Their":[20],"beneficial":[21],"effects":[22,72],"may":[23],"be":[24],"due":[25],"to":[26,82,142],"interference":[27],"in":[28,36,90,129,137],"chronic":[30],"inflammatory":[31,66],"reaction,":[32],"takes":[34],"place":[35],"AD.":[37,155],"The":[38],"best-characterized":[39],"action":[40],"NSAIDs":[42],"is":[43,50],"inhibition":[45],"cyclooxygenase":[47],"(COX).":[48],"There":[49],"special":[51],"interest":[52],"for":[53,149],"treatment":[55,92,151],"AD":[57,94,111,130,138],"using":[58],"selective":[59],"COX-2":[60,86,128],"inhibitors.":[61],"These":[62],"inhibitors":[63],"reduce":[64],"reaction":[67],"but":[68],"lack":[69],"side":[71],"observed":[73],"with":[74],"non-selective":[75],"NSAIDs.":[76],"So":[77],"far,":[78],"clinical":[79],"trials":[80,109],"designed":[81],"inhibit":[83],"inflammation":[84],"or":[85,152],"activity":[87],"have":[88],"failed":[89],"patients.":[95,112],"Several":[96],"lines":[97],"evidence":[99],"can":[100],"explain":[101],"failures":[103],"and":[107,123,127],"anti-COX-2":[108],"on":[110,119],"In":[113],"this":[114],"review":[115],"we":[116],"will":[117],"focus":[118],"role,":[121],"expression":[122],"regulation":[124],"COX-1":[126],"brain.":[131],"Understanding":[132],"role":[134],"COX":[136],"pathogenesis":[139],"could":[140],"contribute":[141],"development":[144],"an":[146],"therapy":[148],"prevention":[153]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2109728136","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
